Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Cervical Cancer, March 2024

Free Subscription


Abstracts

Retrieve all available abstracts of the following 299 articles:
HTML format


 

Single Articles

  1. FANG C, Zhu Y, Zhang P, Zhu T, et al
    The impact of different clinicopathologic factors and salvage therapies on cervical cancer patients with isolated para-aortic lymph node recurrence.
    Discov Oncol. 2024;15:54.
    PubMed    
    Abstract available

  2. WANG C, Wacharasin C, Hengudomsub P
    Self-efficacy as mediators of the association between dyadic coping and quality of life among spousal caregiver of patients with cervical cancer.
    Asia Pac J Oncol Nurs. 2023;11:100354.
    PubMed    
    Abstract available

  3. PANAHI MEYMANDI AR, Akbari B, Soltantoyeh T, Shahosseini Z, et al
    PX-478, an HIF-1alpha inhibitor, impairs mesoCAR T cell antitumor function in cervical cancer.
    Front Oncol. 2024;14:1357801.
    PubMed    
    Abstract available

  4. CHANG SH, Huang KG, Yang LY, Pan YB, et al
    Comparison of outcomes of laparotomic and minimally invasive radical hysterectomy in women with early-stage cervical cancer.
    J Gynecol Oncol. 2024 Feb 23. doi: 10.3802/jgo.2024.
    PubMed    
    Abstract available

  5. BENSELER A, Covens A
    Simple hysterectomy SHAPE-ing up to be the treatment of choice for early cervical cancer under 2 cm.
    J Gynecol Oncol. 2024 Jan 12. doi: 10.3802/jgo.2024.
    PubMed    


  6. PARK JY
    Is it time to change surgery for early-stage low-risk cervical cancer to simple hysterectomy?
    J Gynecol Oncol. 2024 Jan 23. doi: 10.3802/jgo.2024.
    PubMed    


  7. WU H, Fan Y, Bao Y, Zhou Q, et al
    Construction of a ferroptosis and hypoxia-related gene signature in cervical cancer to assess tumour immune microenvironment and predict prognosis.
    J Obstet Gynaecol. 2024;44:2321323.
    PubMed    
    Abstract available

  8. MONK BJ, Mayadev J
    CALLA trial: immunotherapy in locally advanced cervical cancer - Authors' reply.
    Lancet Oncol. 2024;25:e96.
    PubMed    


  9. YANG X, Zhang Y, Jia S, An J, et al
    CALLA trial: immunotherapy in locally advanced cervical cancer.
    Lancet Oncol. 2024;25:e95.
    PubMed    


  10. KOUHEN F, Sqali Houssaini M
    CALLA trial: immunotherapy in locally advanced cervical cancer.
    Lancet Oncol. 2024;25:e94.
    PubMed    


  11. FENG J, He L, Hui JQ, Kavithaa K, et al
    Synthesis of Bimetallic Palladium/Zinc Oxide Nanocomposites Using Crocus sativus and Its Anticancer Activity via the Induction of Apoptosis in Cervical Cancer.
    Appl Biochem Biotechnol. 2024 Feb 29. doi: 10.1007/s12010-024-04877.
    PubMed    
    Abstract available

  12. CHOU HH, Yang CY, Chao A, Lin H, et al
    Consistency in human papillomavirus type detection between self-collected vaginal specimens and physician-sampled cervical specimens.
    J Med Virol. 2024;96:e29426.
    PubMed    
    Abstract available

  13. ASOUDEH-FARD A, Salehi M, Ilghari D, Parsaei A, et al
    Isolated Lactobacillus fermentum Ab.RS22 from traditional dairy products inhibits HeLa cervical cancer cell proliferation and modulates apoptosis by the PTEN-Akt pathway.
    Iran J Basic Med Sci. 2024;27:447-452.
    PubMed    
    Abstract available

  14. WANG L, McQuaid D, Blackledge M, McNair H, et al
    Predicting cervical cancer target motion using a multivariate regression model to enable patient selection for adaptive external beam radiotherapy.
    Phys Imaging Radiat Oncol. 2024;29:100554.
    PubMed    
    Abstract available

  15. YANG H
    The causal correlation between gut microbiota abundance and pathogenesis of cervical cancer: a bidirectional mendelian randomization study.
    Front Microbiol. 2024;15:1336101.
    PubMed    
    Abstract available

  16. WU Z, Chen J, Yang L, Sun K, et al
    Elevated INHBA Promotes Tumor Progression of Cervical Cancer.
    Technol Cancer Res Treat. 2024;23:15330338241234798.
    PubMed    
    Abstract available

  17. VAN VLIET-PEREZ SM, van Paassen R, Wauben LSGL, Straathof R, et al
    Time-action and patient experience analyses of locally advanced cervical cancer brachytherapy.
    Brachytherapy. 2024 Feb 27:S1538-4721(24)00011.
    PubMed    
    Abstract available

  18. WANG GL, Guo N, Zhang JW
    The intact gestational sac of a pregnant patient with cervical cancer: A case report.
    Asian J Surg. 2024 Feb 27:S1015-9584(24)00365.
    PubMed    


  19. MELONI P, Simari T, Roberta L, Cassella I, et al
    Occult invasive cervical cancer, FIGO stage III, with a negative Pap smear test - clinical presentation and brief review of the literature.
    Ceska Gynekol. 2024;89:34-39.
    PubMed    
    Abstract available

  20. STUEBS FA, Behrens AS, Seibold A, Adler W, et al
    Impact of the Corona Pandemic on Cervical Cancer Screening Assessment.
    In Vivo. 2024;38:734-740.
    PubMed    
    Abstract available

  21. PLANTE M, Kwon JS, Ferguson S, Samouelian V, et al
    Simple versus Radical Hysterectomy in Women with Low-Risk Cervical Cancer.
    N Engl J Med. 2024;390:819-829.
    PubMed    
    Abstract available

  22. SATANOVA A, Bolatbekova R, Kukubassov Y, Ossikbayeva S, et al
    Vaccination Effectiveness against Human Papillomavirus in Kazakhstan.
    Asian Pac J Cancer Prev. 2024;25:681-688.
    PubMed    
    Abstract available

  23. MOTAMEDINASAB M, Karimi-Zarchi M, Marzbanrad Z, Mirmohammadi SR, et al
    Lack of Association between TP73 G4C14-A4T14 Polymorphism and Cervical Cancer Risk in Overall and Asian Women: A Meta-Analysis.
    Asian Pac J Cancer Prev. 2024;25:661-670.
    PubMed    
    Abstract available

  24. PANTA S, Rajaram S, Heda A, Bhadoria AS, et al
    Community Screening for High-Risk Human Papilloma Virus Infection using Self-Sampling and 'Point-Of-Care' Test.
    Asian Pac J Cancer Prev. 2024;25:653-659.
    PubMed    
    Abstract available

  25. THIMMAIAH N, Malavade V, A S UK, S S, et al
    Dosimetric Comparison of Isodose Surface Volume and Total Reference Air Kerma (TRAK) based Volume in Cervical Cancer Brachytherapy.
    Asian Pac J Cancer Prev. 2024;25:587-594.
    PubMed    
    Abstract available

  26. SHARMA V, Sinha ES, Singh J
    Investigation of in-vitro Anti-Cancer and Apoptotic Potential of Garlic-Derived Nanovesicles against Prostate and Cervical Cancer Cell Lines.
    Asian Pac J Cancer Prev. 2024;25:575-585.
    PubMed    
    Abstract available

  27. SABRI NA, Shamsuddin SH, Mat Zin AA
    Evaluation of HPV 16 and HPV 18 Oncoprotein Expression as Alternative Diagnostic Tools in Cervical Lesion.
    Asian Pac J Cancer Prev. 2024;25:521-527.
    PubMed    
    Abstract available

  28. THASNEEM P, Sudhager A, Nalini C, J SSR, et al
    Out-reach Colposcopy Clinics and HPV Self-Sampling Decreases Loss to Follow up in a Community based Cervical Cancer Screening Programme.
    Asian Pac J Cancer Prev. 2024;25:419-424.
    PubMed    
    Abstract available

  29. CHEN M, Ye Z, Wang H, Cui X, et al
    Genotype, cervical intraepithelial neoplasia, and type-specific cervical intraepithelial neoplasia distributions in hrHPV+ cases referred to colposcopy: A multicenter study of Chinese mainland women.
    J Med Virol. 2024;96:e29475.
    PubMed    
    Abstract available

  30. DIALLO AA, Codjoe NNA, Ken-Amoah S, Agbeno EK, et al
    Cervical cancer prevention methods: awareness and use among urban Ghanaian women in Cape Coast, West Africa.
    Ecancermedicalscience. 2023;17:1626.
    PubMed    
    Abstract available

  31. OREKOYA AA, Abdus-Salam AA, Oyesegun AR, Ntekim AI, et al
    EGFR and HER2 expression in cervical cancer patients in Ibadan, Nigeria.
    Ecancermedicalscience. 2023;17:1607.
    PubMed    
    Abstract available

  32. AYTENEW TM, Kassie YT, Kebede SD
    Uptake of Cervical Cancer Screening and Its Barriers Using Health Belief Model Among Health Professionals Working in Public Hospitals in South Gondar Zone, Northcentral Ethiopia: Multicenter Cross-Sectional Study.
    Womens Health Rep (New Rochelle). 2024;5:152-160.
    PubMed    
    Abstract available

  33. LI W, Huang Y, Xiao M, Zhao J, et al
    PBRM1 presents a potential ctDNA marker to monitor response to neoadjuvant chemotherapy in cervical cancer.
    iScience. 2024;27:109160.
    PubMed    
    Abstract available

  34. ZHANG J, Niu S, Lu X, Hu R, et al
    Overall survival and short-term efficacy analysis of cervical squamous cell carcinoma with skeletal muscle and (18)F-FDG PET/CT parameters.
    Sci Rep. 2024;14:4809.
    PubMed    
    Abstract available

  35. QIN F, Sun X, Tian M, Jin S, et al
    Prediction of lymph node metastasis in operable cervical cancer using clinical parameters and deep learning with MRI data: a multicentre study.
    Insights Imaging. 2024;15:56.
    PubMed    
    Abstract available

  36. CHEN X, Zhang Z, Wang L, Zhang J, et al
    Homodimeric peptide radiotracer [(68)Ga]Ga-NOTA-(TMVP1)(2) for VEGFR-3 imaging of cervical cancer patients.
    Eur J Nucl Med Mol Imaging. 2024 Feb 27. doi: 10.1007/s00259-024-06661.
    PubMed    
    Abstract available

  37. ZHENG J, Huang B, Xiao L, Wu M, et al
    Effects of BRD4 inhibitor JQ1 on the expression profile of super-enhancer related lncRNAs and mRNAs in cervical cancer HeLa cells.
    PeerJ. 2024;12:e17035.
    PubMed    
    Abstract available

  38. GUAN W, Wang Y, Zhao H, Lu H, et al
    Prediction models for lymph node metastasis in cervical cancer based on preoperative heart rate variability.
    Front Neurosci. 2024;18:1275487.
    PubMed    
    Abstract available

  39. KNOTH J, Sturdza A, Zaharie A, Dick V, et al
    Transrectal ultrasound for intraoperative interstitial needle guidance in cervical cancer brachytherapy.
    Strahlenther Onkol. 2024 Feb 26. doi: 10.1007/s00066-024-02207.
    PubMed    
    Abstract available

  40. CHIGBU CO, Onyebuchi AK, Odugu BU, Ifebi CO, et al
    Pregnancy Outcome Following Treatment of Premalignant Lesion of the Cervix in Southeast Nigeria; A Retrospective Case-Control Study.
    Niger J Clin Pract. 2024;27:215-220.
    PubMed    
    Abstract available

  41. DING F, Liu J, Zhang X
    Retraction Note: MicroRNA-375 released from extracellular vesicles of bone marrow mesenchymal stem cells exerts anti-oncogenic effects against cervical cancer.
    Stem Cell Res Ther. 2024;15:51.
    PubMed    


  42. ALLANSON ER, Zafar SN, Anakwenze CP, Schmeler KM, et al
    The global burden of cervical cancer requiring surgery: database estimates.
    Infect Agent Cancer. 2024;19:5.
    PubMed    
    Abstract available

  43. FAN X, He W, Zhang Q, Zhang B, et al
    Evaluation and Prediction Analysis of 3- and 5-Year Relative Survival Rates of Patients with Cervical Cancer: A Model-Based Period Analysis.
    Cancer Control. 2024;31:10732748241232324.
    PubMed    
    Abstract available

  44. EMERSON A, Dogan M, Hawes E, Wilson K, et al
    Cervical cancer screening barriers and facilitators from the perspectives of women with a history of criminal-legal system involvement and substance use.
    Health Justice. 2024;12:9.
    PubMed    
    Abstract available

  45. ZHANG S, Lin X, Xiao L, Wang Y, et al
    Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity.
    J Vis Exp. 2024;.
    PubMed    
    Abstract available

  46. YU C, Xu J, Xu S, Tang L, et al
    Exploring genetic associations of Crohn's disease and ulcerative colitis with extraintestinal cancers in European and East Asian populations.
    Front Immunol. 2024;15:1339207.
    PubMed    
    Abstract available

  47. CHAKRABARTI D, Qayoom S, Srivastava K, Resu AV, et al
    Cancer stem cell biomarkers SOX2 and Oct4 in cervical cancer patients undergoing chemoradiotherapy.
    Asia Pac J Clin Oncol. 2024 Feb 25. doi: 10.1111/ajco.14049.
    PubMed    
    Abstract available

  48. SHAN Y, Ding Z, Chen A, Cui Z, et al
    Incidence, prognostic factors, and a nomogram of cervical cancer with lung metastasis: A SEER-based study.
    J Gynecol Obstet Hum Reprod. 2024;53:102757.
    PubMed    
    Abstract available

  49. ZHANG L, Ju Y, Hu H, Ma C, et al
    Analytical evaluation of the automated genotyping system (GenPlex) compared to a traditional real-time PCR assay for the detection of high-risk human papillomaviruses.
    J Med Virol. 2024;96:e29496.
    PubMed    
    Abstract available

  50. OU-YANG X, Cao Y, Leng Q, Wang Y, et al
    Eliminating cervical cancer in China: Opportunities come and challenges remain.
    J Med Virol. 2024;96:e29480.
    PubMed    


  51. HONDA KI, Miyama M, Nishii Y, Tasaka R, et al
    Metastasis of cervical cancer indicated by elevation of serum CA125 produced by mediastinal lymph nodes: a case report.
    J Med Case Rep. 2024;18:112.
    PubMed    
    Abstract available

  52. BIZZARRI N, Di Berardino S, Benkortbi K, Balaya V, et al
    External beam radiotherapy boost versus surgical debulking followed by radiotherapy for the treatment of metastatic lymph nodes in cervical cancer: A systematic review and meta-analysis.
    Eur J Surg Oncol. 2024;50:108013.
    PubMed    
    Abstract available

  53. JIANG P, Jiang W, Li X, Zhu Q, et al
    Combination of Formononetin and Sulforaphane Natural Drug Repress the Proliferation of Cervical Cancer Cells via Impeding PI3K/AKT/mTOR Pathway.
    Appl Biochem Biotechnol. 2024 Feb 24. doi: 10.1007/s12010-024-04873.
    PubMed    
    Abstract available

  54. SRINATH S, Jishnu PV, Varghese VK, Shukla V, et al
    Regulation and tumor-suppressive function of the miR-379/miR-656 (C14MC) cluster in cervical cancer.
    Mol Oncol. 2024 Feb 23. doi: 10.1002/1878-0261.13611.
    PubMed    
    Abstract available

  55. ZHITKEVICH A, Bayurova E, Avdoshina D, Zakirova N, et al
    HIV-1 Reverse Transcriptase Expression in HPV16-Infected Epidermoid Carcinoma Cells Alters E6 Expression and Cellular Metabolism, and Induces a Hybrid Epithelial/Mesenchymal Cell Phenotype.
    Viruses. 2024;16:193.
    PubMed    
    Abstract available

  56. WEYKAMP F, Meixner E, Arians N, Hoegen-Sassmannshausen P, et al
    Daily AI-Based Treatment Adaptation under Weekly Offline MR Guidance in Chemoradiotherapy for Cervical Cancer 1: The AIM-C1 Trial.
    J Clin Med. 2024;13:957.
    PubMed    
    Abstract available

  57. UBINHA ACF, Pedrao PG, Tadini AC, Schmidt RL, et al
    The Role of Pelvic Exenteration in Cervical Cancer: A Review of the Literature.
    Cancers (Basel). 2024;16:817.
    PubMed    
    Abstract available

  58. FISCHEROVA D, Fruhauf F, Burgetova A, Haldorsen IS, et al
    The Role of Imaging in Cervical Cancer Staging: ESGO/ESTRO/ESP Guidelines (Update 2023).
    Cancers (Basel). 2024;16:775.
    PubMed    
    Abstract available

  59. OLTHOF EP, Wenzel HHB, van der Velden J, Stalpers LJA, et al
    Treatment Strategies Guided by [18F]FDG-PET/CT in Patients with Locally Advanced Cervical Cancer and [18F]FDG-Positive Lymph Nodes.
    Cancers (Basel). 2024;16:717.
    PubMed    
    Abstract available

  60. SAITO T, Imahashi K, Yamaki C
    Use of General Health Examination and Cancer Screening among People with Disability Who Need Support from Others: Analysis of the 2016 Comprehensive Survey of Living Conditions in Japan.
    Int J Environ Res Public Health. 2024;21:219.
    PubMed    
    Abstract available

  61. BERMUDEZ Y, Scott L, Miller J, DeGroff A, et al
    Are National Breast and Cervical Cancer Early Detection Program Recipients Providing Services in Counties Heavily Burdened by Breast and Cervical Cancer?
    Int J Environ Res Public Health. 2024;21:188.
    PubMed    
    Abstract available

  62. TAYLOR EV, Dugdale S, Connors CM, Garvey G, et al
    "A Huge Gap": Health Care Provider Perspectives on Cancer Screening for Aboriginal and Torres Strait Islander People in the Northern Territory.
    Int J Environ Res Public Health. 2024;21:141.
    PubMed    
    Abstract available

  63. OUH YT, Kim HY, Yi KW, Lee NW, et al
    Enhancing Cervical Cancer Screening: Review of p16/Ki-67 Dual Staining as a Promising Triage Strategy.
    Diagnostics (Basel). 2024;14:451.
    PubMed    
    Abstract available

  64. NAERT E, Van Hulle H, De Jaeghere EA, Orije MRP, et al
    Sexual health in Belgian cervical cancer survivors: an exploratory qualitative study.
    Qual Life Res. 2024 Feb 24. doi: 10.1007/s11136-024-03603.
    PubMed    
    Abstract available

  65. PARVEZ R, Vijayachari P, Thiruvengadam K, Roy A, et al
    A population based study on human papillomavirus infection and associated risk factors among women of the remote South Andaman Island, India.
    BMC Womens Health. 2024;24:139.
    PubMed    
    Abstract available

  66. LI M, Chen J, Zhang H, Zhang Y, et al
    LOC644656 promotes cisplatin resistance in cervical cancer by recruiting ZNF143 and activating the transcription of E6-AP.
    Cell Signal. 2024 Feb 21:111115. doi: 10.1016/j.cellsig.2024.111115.
    PubMed    
    Abstract available

  67. MIZUNO H, Nakaji T, Fukuda S, Kato S, et al
    End-to-end dosimetry audit for three-dimensional image-guided brachytherapy for cervical cancer.
    Phys Med. 2024;119:103321.
    PubMed    
    Abstract available

  68. WASHINGTON A, Smith L, Randall J, Anderson G, et al
    A Systematic Review of the Effectiveness of Cervical Cancer Screening and Prevention Interventions for African American Women: Implications for Promoting Health Equity.
    J Womens Health (Larchmt). 2024 Feb 23. doi: 10.1089/jwh.2023.0635.
    PubMed    
    Abstract available

  69. KILINC ISLEYEN E, Korkmaz Aslan G, Kartal A
    Knowledge and Perceptions About Cervical Cancer and Human Papillomavirus, and Relationship with E-health Literacy, and Affecting Factors Among Female University Students.
    J Adolesc Young Adult Oncol. 2024 Feb 23. doi: 10.1089/jayao.2023.0173.
    PubMed    
    Abstract available

  70. SONDER GJB, Grey C, Ryan D, Cumming J, et al
    Selective under-representation of Pacific peoples in population estimates for health indicator measurements in Aotearoa New Zealand misinforms policy making.
    BMC Public Health. 2024;24:564.
    PubMed    
    Abstract available

  71. MU J, Cao Y, Zhong X, Diao W, et al
    Prediction of cervical lymph node metastasis in differentiated thyroid cancer based on radiomics models.
    Br J Radiol. 2024;97:526-534.
    PubMed    
    Abstract available

  72. BARRA M, Chang M, Salcedo MP, Schmeler K, et al
    Single-tube four-target lateral flow assay detects human papillomavirus types associated with majority of cervical cancers.
    Anal Biochem. 2024;688:115480.
    PubMed    
    Abstract available

  73. GUERRA S, Roope LS, Tsiachristas A
    Assessing the relationship between coverage of essential health services and poverty levels in low- and middle-income countries.
    Health Policy Plan. 2024;39:156-167.
    PubMed    
    Abstract available

  74. ANDERSON LE, Collins KE, Myers L, Ireland MJ, et al
    Decisions and prompts to screen for cervical, bowel, and breast cancer.
    Patient Educ Couns. 2024;122:108174.
    PubMed    
    Abstract available

  75. YUCEL E, Koca Yildirim HE, Sahin Duran F, Cakir C, et al
    The role of cervical elastography in the differential diagnosis of preinvasive and invasive lesions of the cervix.
    Arch Gynecol Obstet. 2024;309:1585-1595.
    PubMed    
    Abstract available

  76. RENAUD J, Buissonniere P, Dulau C, Deloire M, et al
    Gynaecological follow-up for women of reproductive age with multiple sclerosis: The GYNESEP study.
    Mult Scler Relat Disord. 2024;83:105448.
    PubMed    
    Abstract available

  77. AHADINEZHAD B, Maleki A, Amerzadeh M, Mohtashamzadeh B, et al
    What rate of Iranian women perform Pap smear test? Results from a meta-analysis.
    Prev Med. 2024;180:107871.
    PubMed    
    Abstract available

  78. BAEK SU, Lee YM, Yoon JH
    Association between long working hours and engagement in preventive healthcare services in Korean workers: Findings from the Korean National Health and Nutrition Examination Survey.
    Prev Med. 2024;180:107849.
    PubMed    
    Abstract available

  79. URWIN S, Gillibrand S, Davies JC, Crosbie EJ, et al
    Factors associated with cervical screening coverage: a longitudinal analysis of English general practices from 2013 to 2022.
    J Public Health (Oxf). 2024;46:e43-e50.
    PubMed    
    Abstract available

  80. NAEGELE S, Ruiz-Torres DA, Zhao Y, Goss D, et al
    Comparing the Diagnostic Performance of Quantitative PCR, Digital Droplet PCR, and Next-Generation Sequencing Liquid Biopsies for Human Papillomavirus-Associated Cancers.
    J Mol Diagn. 2024;26:179-190.
    PubMed    
    Abstract available

  81. KUENKEL E, Jaeger A, Bohlmann I, Bergauer F, et al
    The use of colposcopy for triage in HPV-positive women aged 65 years and older.
    Arch Gynecol Obstet. 2024;309:1561-1567.
    PubMed    
    Abstract available

  82. YADAV R, Bhawale R, Kapoor DN, Singh SB, et al
    Experimental design approach for development of carboplatin loaded chitosan modified liposomal formulation with improved topical vaginal therapeutic potential.
    Pharm Dev Technol. 2024;29:1-12.
    PubMed    
    Abstract available

  83. BAO Y, Zhang H, Huang W, Luo X, et al
    Novel predictors for identifying cervical minimal deviation adenocarcinoma patients with poor prognosis: a long-term observational study in a tertiary centre.
    Arch Gynecol Obstet. 2024;309:1483-1490.
    PubMed    
    Abstract available

  84. REYNOSO-NOVERON N, Torres-Dominguez JA, Morales-Juarez L, Mohar-Betancourt A, et al
    Analysis of cancer mortality in Mexico using the results of the Global Burden of Disease 2021 study.
    Gac Med Mex. 2023;159:574-581.
    PubMed    
    Abstract available

  85. SONG YL, Li RZ, Feng BJ, Lu YH, et al
    Survival after minimally invasive radical hysterectomy with protective colpotomy for early-stage cervical cancer: A systematic review and meta-analysis.
    Eur J Surg Oncol. 2024;50:108240.
    PubMed    
    Abstract available

  86. YOON HJ, Kwon BS, Rho HJ, Lee TH, et al
    Comparison of survival outcome of open, total laparoscopic, and laparoscopy-assisted radical vaginal hysterectomy for stage IB2 cervical cancer patients: A multicenter retrospective study.
    Medicine (Baltimore). 2024;103:e37426.
    PubMed    
    Abstract available

  87. ZHANG Z, Sun B, Lu J, Bai P, et al
    Norcantharidin inhibits the malignant progression of cervical cancer by inducing endoplasmic reticulum stress.
    Mol Med Rep. 2024;29:71.
    PubMed    
    Abstract available

  88. NITTALA MR, Yang J, Velazquez AE, Salvemini JD, et al
    Precision Population Cancer Medicine in Cancer of the Uterine Cervix: A Potential Roadmap to Eradicate Cervical Cancer.
    Cureus. 2024;16:e53733.
    PubMed    
    Abstract available

  89. LI X, Ning R, Xiao B, Meng S, et al
    A multi-variable predictive warning model for cervical cancer using clinical and SNPs data.
    Front Med (Lausanne). 2024;11:1294230.
    PubMed    
    Abstract available

  90. LIU L, Huang L, Deng L, Li F, et al
    Bioinformatics identification of characteristic genes of cervical cancer via an artificial neural network.
    Chin Clin Oncol. 2024;13:4.
    PubMed    
    Abstract available

  91. SHI R, Chang L, Shi L, Zhang Z, et al
    Development and validation of a prognostic model for cervical cancer by combination of machine learning and high-throughput sequencing.
    Eur J Surg Oncol. 2024;50:108241.
    PubMed    
    Abstract available

  92. WANG C, Zhang M, Peng J, Zhang M, et al
    Combining cisplatin with Pinellia pedatisecta Schott lipid-soluble extract induces tumor immunogenic cell death in cervical cancer.
    Phytomedicine. 2024;128:155504.
    PubMed    
    Abstract available

  93. LUO PH, Mo DC, Wang HL, Liang XJ, et al
    Predicted Value of PD-L1 for Patients With Cervical Cancer Treated With Pembrolizumab.
    J Clin Oncol. 2024 Mar 7:JCO2302479. doi: 10.1200/JCO.23.02479.
    PubMed    


  94. FENNELL BS, Jones SR, Sutton SK, Hoogland CE, et al
    In-Clinic vs. Online Recruitment of Women with a History of Cervical Intraepithelial Neoplasia or Cervical Cancer to a Smoking Cessation Trial: A Post-hoc Comparison of Participant Characteristics, Study Retention, and Cessation Outcomes.
    Nicotine Tob Res. 2024 Mar 7:ntae049. doi: 10.1093.
    PubMed    
    Abstract available

  95. LUIZ ODC, Nisida V, Silva Filho AMD, Souza ASP, et al
    Racial iniquity in mortality from cervical cancer in Brazil: a time trend study from 2002 to 2021.
    Cien Saude Colet. 2024;29:e05202023.
    PubMed    
    Abstract available

  96. XU X, Ping P, Zhang Z, Zou L, et al
    Plasma free fatty acid levels in cervical cancer: concurrent chemoradiotherapy improves abnormal profile.
    Front Pharmacol. 2024;15:1352101.
    PubMed    
    Abstract available

  97. WANG Y, Xu M, Yao Y, Li Y, et al
    Extracellular cancer?associated fibroblasts: A novel subgroup in the cervical cancer microenvironment that exhibits tumor?promoting roles and prognosis biomarker functions.
    Oncol Lett. 2024;27:167.
    PubMed    
    Abstract available

  98. IWATA T, Matsui T, Matsuda R, Katoh Y, et al
    [?. Immunotherapy in Cervical Cancer-Current Approaches and Future Horizons].
    Gan To Kagaku Ryoho. 2024;51:134-137.
    PubMed    


  99. AHN SY
    Mitofusin-2 enhances cervical cancer progression through Wnt/beta-catenin signaling.
    BMB Rep. 2024 Mar 7:6097.
    PubMed    
    Abstract available

  100. OLALEYE OO, Kim DH, Spriggs KA
    Antiproliferative activities of some selected Nigerian medicinal plants against breast, liver, and cervical cancer cells.
    BMC Complement Med Ther. 2024;24:110.
    PubMed    
    Abstract available

  101. ROMERO D
    Non-inferiority of simple versus radical hysterectomy in low-risk cervical cancer.
    Nat Rev Clin Oncol. 2024 Mar 6. doi: 10.1038/s41571-024-00879.
    PubMed    


  102. LI X, He S, Zhao X, Sun D, et al
    High-grade cervical lesions diagnosed by JAM3/PAX1 methylation in high-risk human papillomavirus-infected patients.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2023;48:1820-1829.
    PubMed    
    Abstract available

  103. WENTZENSEN N, Garcia F, Clarke MA, Massad LS, et al
    Enduring Consensus Guidelines for Cervical Cancer Screening and Management: Introduction to the Scope and Process.
    J Low Genit Tract Dis. 2024 Mar 6. doi: 10.1097/LGT.0000000000000804.
    PubMed    
    Abstract available

  104. SINHA A, Ghosh S, Ghosh A, Ghosh A, et al
    Unfurling the functional association between long intergenic noncoding RNAs (lincRNAs) and HPV16-related cervical cancer pathogenesis through weighted gene co-expression network analysis of differentially expressed lincRNAs and coding genes.
    Carcinogenesis. 2024 Mar 6:bgae019. doi: 10.1093.
    PubMed    
    Abstract available

  105. SOLEIMANI-JELODAR R, Arashkia A, Shoja Z, Akhavan S, et al
    The expression analysis of human endogenous retrovirus-K Env, Np9, and Rec transcripts in cervical cancer.
    J Med Virol. 2024;96:e29501.
    PubMed    
    Abstract available

  106. VILASBOAS-RIBEIRO I, Sumser K, Nouwens S, Feddersen T, et al
    Adapting Temperature Predictions to MR Imaging in Treatment Position to Improve Simulation-Guided Hyperthermia for Cervical Cancer.
    IEEE Open J Eng Med Biol. 2023;5:99-106.
    PubMed    
    Abstract available

  107. ANYOLO E, Amakali K, Amukugo HJ
    Attitudes of women towards screening, prevention and treatment of cervical cancer in Namibia.
    Health SA. 2024;29:2433.
    PubMed    
    Abstract available

  108. SONG X, Li X, Tan Z, Zhang L, et al
    Recent status and trends of nanotechnology in cervical cancer: a systematic review and bibliometric analysis.
    Front Oncol. 2024;14:1327851.
    PubMed    
    Abstract available

  109. JIANG M, Wu R, Liu D, Wang X, et al
    Utilizing Ni(II) complex for metal drug-gel particles in cervical cancer treatment and designing novel drugs through machine learning methods.
    Sci Rep. 2024;14:5421.
    PubMed    
    Abstract available

  110. SAITSU Y, Yoneda S, Fukuta K
    Management of a pregnant woman with a large cervical polyp and moderate genital bleeding in the first trimester.
    BMJ Case Rep. 2024;17:e258163.
    PubMed    
    Abstract available

  111. SHARMA V, Sinha ES, Singh J
    Investigation of In Vitro Anti-cancer and Apoptotic Potential of Onion-Derived Nanovesicles Against Prostate and Cervical Cancer Cell Lines.
    Appl Biochem Biotechnol. 2024 Mar 5. doi: 10.1007/s12010-024-04872.
    PubMed    
    Abstract available

  112. MAZUREC K, Trzeszcz M, Mazurec M, Streb J, et al
    Should we use risk selection tests for HPV 16 and/or 18 positive cases: Comparison of p16/Ki67 and cytology.
    J Med Virol. 2024;96:e29500.
    PubMed    
    Abstract available

  113. SHANAZAROV NA, Zare A, Mussin NM, Albayev RK, et al
    Photodynamic therapy of cervical cancer: a scoping review on the efficacy of various molecules.
    Ther Adv Chronic Dis. 2024;15:20406223241233206.
    PubMed    
    Abstract available

  114. DANIELS J, Asante K, Tackie JNO, Kyei KA, et al
    Survival rate of cervical cancer: a five year review at a Major Teaching Hospital in Ghana, West Africa.
    Ecancermedicalscience. 2024;18:1663.
    PubMed    
    Abstract available

  115. CHEN W, Wang R, Wu J, Wu Y, et al
    Comparison of surgical and oncological outcomes between different surgical approaches for overweight or obese cervical cancer patients.
    J Robot Surg. 2024;18:107.
    PubMed    
    Abstract available

  116. YE D, Duan X, Guan B, Yuan J, et al
    Biomarker cystatin B expression correlates with pathogenesis in cervical cancer.
    J Int Med Res. 2024;52:3000605241233959.
    PubMed    
    Abstract available

  117. KAIKSOW FA, Burns M, Krebsbach J, Lasarev MR, et al
    Cervical Cancer and a History of Incarceration: Examining a Social Determinant of Health.
    J Correct Health Care. 2024 Mar 1. doi: 10.1089/jchc.23.05.0047.
    PubMed    
    Abstract available

  118. ROMLI R, Mohd Hashim S, Abd Rahman R, Chew KT, et al
    Understanding cervical cancer screening motivations from women and health practitioners' perspectives: A qualitative exploration.
    Gynecol Oncol Rep. 2024;52:101349.
    PubMed    
    Abstract available

  119. HEIDARI-EZZATI S, Moeinian P, Ahmadian-Nejad B, Maghbbouli F, et al
    The role of long non-coding RNAs and circular RNAs in cervical cancer: modulating miRNA function.
    Front Cell Dev Biol. 2024;12:1308730.
    PubMed    
    Abstract available

  120. ZHENG N, Tang J, Ren XM
    [Common Malignant Tumors in the Reproductive System of Chinese Women: Disease Burden During 1990-2019 and Prediction of Future Trend].
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2024;46:25-32.
    PubMed    
    Abstract available

  121. PAL A, Sengupta S, Kundu R
    Corrigendum to "Tiliacora racemosa leaves induce oxidative stress mediated DNA damage leading to G2/M phase arrest and apoptosis in cervical cancer cells SiHa" [J. Ethnopharmacol. 269 (2021) 113686].
    J Ethnopharmacol. 2024 Mar 2:117916. doi: 10.1016/j.jep.2024.117916.
    PubMed    


  122. ZHAO J, Liu Q, Jiang D, Chen T, et al
    Comparative study of tumor-free laparoscopic and open surgery in the treatment of early-stage cervical cancer.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2023;48:1686-1695.
    PubMed    
    Abstract available

  123. ZAROCOSTAS J
    Renewed calls to scale-up cervical cancer screening.
    Lancet. 2024;403:797.
    PubMed    


  124. LU Z, Fan P, Huo W, Feng Y, et al
    Genomic profiles and their relationships with clinical characteristics and immune features in cervical cancer.
    Transl Oncol. 2024;44:101923.
    PubMed    
    Abstract available

  125. REN J, Chen X, Li J, Zan Y, et al
    TET1 inhibits the migration and invasion of cervical cancer cells by regulating autophagy.
    Epigenetics. 2024;19:2323751.
    PubMed    
    Abstract available

  126. XU H, Ding H, Ge Q, Shi C, et al
    The effects of laparoscopic and laparotomy extensive hysterectomy on the safety of ureterovaginal fistula infection in patients with cervical cancer.
    Cell Mol Biol (Noisy-le-grand). 2024;70:281-284.
    PubMed    
    Abstract available

  127. HOLLINGTON M
    Cox proportional hazard-model application: time to cervical cancer screening among women living with HIV in South Africa.
    Infect Agent Cancer. 2024;19:6.
    PubMed    
    Abstract available

  128. WU J, Tang J, Luo Y, Li W, et al
    Intraoperative implantation of 125I seeds improves prognosis in refractory stage IIIB cervical cancer: a case report and literature review.
    BMC Womens Health. 2024;24:153.
    PubMed    
    Abstract available

  129. COUTINHO F, Gokhale M, Doran C, Monberg M, et al
    Characteristics, treatment patterns, and outcomes in patients with high-risk locally advanced cervical cancer.
    Cancer Treat Res Commun. 2024;39:100800.
    PubMed    
    Abstract available

  130. BIAN Z, Wu X, Chen Q, Gao Q, et al
    Oct4 activates IL-17A to orchestrate M2 macrophage polarization and cervical cancer metastasis.
    Cancer Immunol Immunother. 2024;73:73.
    PubMed    
    Abstract available

  131. ZHANG J, Zha T, Wang X, He W, et al
    Prevalence and genotype distribution of HPV infections among women in Chengdu,China.
    Virol J. 2024;21:52.
    PubMed    
    Abstract available

  132. TEKPOR E, Effah K, Sifa J, Amuah JE, et al
    Prevalence of high-risk human papillomavirus infection and cervical lesions among female migrant head porters (kayayei) in Accra, Ghana: a pilot cross-sectional study.
    BMC Public Health. 2024;24:659.
    PubMed    
    Abstract available

  133. WANG H, Li C, Wei Q, Zhang E, et al
    RBM15 Knockdown Impairs the Malignancy of Cervical Cancer by Mediating m6A Modification of Decorin.
    Biochem Genet. 2024 Mar 1. doi: 10.1007/s10528-024-10757.
    PubMed    
    Abstract available

  134. PIAO L, Xiang P, Zhou Y, Zhao W, et al
    Thermo-sensitive PLGA-PEG-PLGA hydrogel for sustained release of EGF to inhibit cervical cancer recurrence.
    Colloids Surf B Biointerfaces. 2024;236:113795.
    PubMed    
    Abstract available

  135. PALMER C, Dolk C, Sabale U, Wang W, et al
    Cost-effectiveness of nonavalent HPV vaccination in the Netherlands.
    Expert Rev Vaccines. 2024;23:312-323.
    PubMed    
    Abstract available

  136. MARTINELLI M, Latsuzbaia A, Bonde J, Pedersen H, et al
    Performance of BD Onclarity HPV assay on FLOQSwabs vaginal self-samples.
    Microbiol Spectr. 2024;12:e0287223.
    PubMed    
    Abstract available

  137. ZHAO X, Singhal A, Park S, Kong J, et al
    Cancer Mutations Converge on a Collection of Protein Assemblies to Predict Resistance to Replication Stress.
    Cancer Discov. 2024;14:508-523.
    PubMed    
    Abstract available

  138. AGGARWAL S, Agarwal P, Gupta N
    A comprehensive narrative review of challenges and facilitators in the implementation of various HPV vaccination program worldwide.
    Cancer Med. 2024;13:e6862.
    PubMed    
    Abstract available

  139. HUANG Y, Kang Y, Li Y, Cai L, et al
    HPV positivity status in males is related to the acquisition of HPV infection in females in heterosexual couples.
    Eur J Clin Microbiol Infect Dis. 2024 Jan 4. doi: 10.1007/s10096-023-04722.
    PubMed    
    Abstract available

  140. DE JONG A, Baeten IGT, Jansen A, Hoogendam JP, et al
    Symptomatic Lymphocele After Robot-Assisted Pelvic Lymphadenectomy as Part of the Primary Surgical Treatment for Cervical and Endometrial Cancer: A Retrospective Cohort Study.
    J Minim Invasive Gynecol. 2024;31:243-249.
    PubMed    
    Abstract available

  141. WANG B, Zhang C, Su Y, Yuan S, et al
    Comparative study of topical 5-aminolevulinic acid photodynamic therapy and surgery in treating vaginal high-grade squamous intraepithelial lesions following hysterectomy.
    Photodiagnosis Photodyn Ther. 2024;45:103921.
    PubMed    
    Abstract available

  142. OREN EDT, Kiziltas S
    Sexual quality of life between healthy women and women with gynecological cancer: Results of a hospital-based case-control study in Turkiye.
    J Obstet Gynaecol Res. 2024;50:456-466.
    PubMed    
    Abstract available

  143. SHANAZAROV N, Bariyeva G, Avdeyev A, Albayev R, et al
    Evaluation of the effectiveness and safety of photodynamic therapy in the treatment of precancerous diseases of the cervix (neoplasia) associated with the human papillomavirus: A systematic review.
    Photodiagnosis Photodyn Ther. 2024;45:103925.
    PubMed    
    Abstract available

  144. DAVARO E, Tinnirello AA, Bevers TB, Milbourne A, et al
    Efficacy of Cobas HPV testing for predicting grade 2+ cervical intraepithelial neoplasia in a cancer prevention center and a gynecologic oncology clinic: A single-institution experience.
    Cancer Cytopathol. 2024;132:152-160.
    PubMed    
    Abstract available

  145. WHITTAKER M, Davies JC, Sargent A, Sawyer M, et al
    A comparison of the carbon footprint of alternative sampling approaches for cervical screening in the UK: A descriptive study.
    BJOG. 2024;131:699-708.
    PubMed    
    Abstract available

  146. RAY S, Mulchandani R, Patel P
    Demand and willingness to pay for human papilloma virus vaccine for their daughters among mothers in Haryana, India: A contingent valuation study.
    J Health Serv Res Policy. 2024;29:76-83.
    PubMed    
    Abstract available

  147. RUBAGUMYA F, Wilson B, Manirakiza A, Mutabazi E, et al
    Financial Toxicity: Unveiling the Burden of Cancer Care on Patients in Rwanda.
    Oncologist. 2024;29:e345-e350.
    PubMed    
    Abstract available

  148. LI X, Ren C, Huang A, Zhao Y, et al
    PIBF1 regulates multiple gene expression via impeding long-range chromatin interaction to drive the malignant transformation of HPV16 integration epithelial cells.
    J Adv Res. 2024;57:163-180.
    PubMed    
    Abstract available

  149. DAU H, Nankya E, Naguti P, Basemera M, et al
    The economic burden of cervical cancer on women in Uganda: Findings from a cross-sectional study conducted at two public cervical cancer clinics.
    PLOS Glob Public Health. 2024;4:e0002554.
    PubMed    
    Abstract available

  150. CHEN F, Gong X, Zhang K, Yu Y, et al
    Nomogram Predicting Grade >/=2 Acute Radiation Enteritis in Patients With Cervical Cancer Receiving Concurrent Chemoradiotherapy.
    Am J Clin Oncol. 2024 Mar 15. doi: 10.1097/COC.0000000000001096.
    PubMed    
    Abstract available

  151. LIU CK, Huang KG, Chen MJ, Lu CH, et al
    The Current Trend of Fertility Preservation in Patients with Cervical Cancer.
    Gynecol Minim Invasive Ther. 2023;13:4-9.
    PubMed    
    Abstract available


  152. Erratum: A Comparison of Conventional Pap Smear and Liquid-Based Cytology for Cervical Cancer Screening.
    Gynecol Minim Invasive Ther. 2024;13:68.
    PubMed    
    Abstract available

  153. PALAGUDI M, Para S, Golla N, Meduri KC, et al
    Adverse Effects of Cancer Treatment in Patients With Cervical Cancer.
    Cureus. 2024;16:e54106.
    PubMed    
    Abstract available

  154. OTSUKA I
    Peritoneal Recurrence of Squamous Cell Carcinoma in a Young Woman After Conization for Microinvasive Cervical Cancer.
    Cureus. 2024;16:e54091.
    PubMed    
    Abstract available

  155. TSEGAYE AT, Lin J, Cole A, Szpiro AA, et al
    Association of Maternal Cervical Cancer Screening Adherence with Adolescent HPV Vaccination Among Adolescent-Mother Pairs.
    J Community Health. 2024 Mar 14. doi: 10.1007/s10900-024-01333.
    PubMed    
    Abstract available

  156. XIAO Y, Chen W, Long X, Li M, et al
    3D MR elastography-based stiffness as a marker for predicting tumor grade and subtype in cervical cancer.
    Magn Reson Imaging. 2024 Mar 12:S0730-725X(24)00062.
    PubMed    
    Abstract available

  157. HWANG WY, Choi CH, Kim K, Kim MH, et al
    Determination of ovarian transposition through prediction of postoperative adjuvant therapy in young patients with early stage cervical cancer undergoing surgery: a Korean multicenter retrospective study (KGOG 1042).
    Obstet Gynecol Sci. 2024 Mar 14. doi: 10.5468/ogs.23291.
    PubMed    
    Abstract available

  158. DONG Y, Jiang G, Qu H, Zhuang H, et al
    Effectiveness of a narrative nursing intervention on reproductive concerns in women of childbearing age undergoing cervical cancer surgery: A randomized controlled trial.
    Eur J Oncol Nurs. 2024;70:102537.
    PubMed    
    Abstract available

  159. KE Y, Zhang Z, Li Y, Qin Y, et al
    Prognostic value of lymph node ratio in patients with non-metastatic cervical cancer treated with radical hysterectomy: A population-based study.
    Eur J Surg Oncol. 2024;50:108258.
    PubMed    
    Abstract available

  160. CHAPMAN HL, Dholakia JJ, Marcrom S, Liang M, et al
    Treatment of Cervical Cancer Complicated by Advanced Pelvic Organ Prolapse: A Case Report.
    Urogynecology (Phila). 2024;30:309-313.
    PubMed    
    Abstract available


  161. Retraction: miR-212/132 downregulates SMAD2 expression to suppress the G1/S phase transition of the cell cycle and the epithelial to mesenchymal transition in cervical cancer cells.
    IUBMB Life. 2024 Mar 14. doi: 10.1002/iub.2815.
    PubMed    
    Abstract available

  162. SHALABY NA, Tudorescu-Morjan C, Manole CG, Iacata AA, et al
    Correlation between high-risk HPV infection and p16/Ki-67 abnormalities in Pap samples in a South Eastern Europe cohort.
    J Med Virol. 2024;96:e29524.
    PubMed    
    Abstract available

  163. YADAV P, Gaurav A, Ravi AK, Khoiwal K, et al
    Cervical cancer awareness, knowledge, behavioural patterns, and practice of screening and vaccination in females of hilly regions of North India - A hospital-based observational study.
    J Family Med Prim Care. 2024;13:43-47.
    PubMed    
    Abstract available

  164. ZHAO M, Gao MZ, Gu RY, Luo L, et al
    The Risk of Cervical Cancer in Women Among Han, Bai, Dai and Hani Ethnic Minorities in Yunnan Province of China.
    Int J Womens Health. 2024;16:373-384.
    PubMed    
    Abstract available

  165. LIN Z, Li X, Shi H, Cao R, et al
    Decoding the tumor microenvironment and molecular mechanism: unraveling cervical cancer subpopulations and prognostic signatures through scRNA-Seq and bulk RNA-seq analyses.
    Front Immunol. 2024;15:1351287.
    PubMed    
    Abstract available

  166. MA C, Zou M, Xu N, Liu Y, et al
    Portable, and ultrasensitive HR-HPV tests based on nucleic acid biosensors.
    Front Cell Infect Microbiol. 2024;14:1357090.
    PubMed    
    Abstract available

  167. DONG EE, Xu J, Kim JW, Bryan J, et al
    Apparent diffusion coefficient values predict response to brachytherapy in bulky cervical cancer.
    Radiat Oncol. 2024;19:35.
    PubMed    
    Abstract available

  168. DONG X, Zhan Y, Li S, Yang M, et al
    MKRN1 regulates the expression profiles and transcription factor activity in HeLa cells inhibition suppresses cervical cancer cell progression.
    Sci Rep. 2024;14:6129.
    PubMed    
    Abstract available

  169. LONG J, Chen X, He M, Ou S, et al
    HLA-class II restricted TCR targeting human papillomavirus type 18 E7 induces solid tumor remission in mice.
    Nat Commun. 2024;15:2271.
    PubMed    
    Abstract available

  170. KURATSUNE K, Ueda T, Tajiri R, Tohyama A, et al
    [A Case of Adenocarcinoma, HPV-independent, Mesonephric Type with Significant Response to Neoadjuvant Chemotherapy].
    J UOEH. 2024;46:45-51.
    PubMed    
    Abstract available

  171. SHELTON J, Zotow E, Smith L, Johnson SA, et al
    25 year trends in cancer incidence and mortality among adults aged 35-69 years in the UK, 1993-2018: retrospective secondary analysis.
    BMJ. 2024;384:e076962.
    PubMed    
    Abstract available

  172. GOCIMAN S, Florell SR, Clarke JT
    Cutaneous metastasis as a first sign of adenocarcinoma of the cervix.
    Dermatol Online J. 2023;29.
    PubMed    
    Abstract available

  173. JIN S, Wang W, Xu X, Yu Z, et al
    miR-34b-3p-mediated regulation of STC2 and FN1 enhances chemosensitivity and inhibits proliferation in cervical cancer.
    Acta Biochim Biophys Sin (Shanghai). 2024 Mar 13. doi: 10.3724/abbs.2024009.
    PubMed    
    Abstract available

  174. FENG J, Wang T
    [Retracted] MicroRNA?873 serves a critical role in human cervical cancer proliferation and metastasis via regulating glioma?associated oncogene homolog 1.
    Exp Ther Med. 2024;27:163.
    PubMed    
    Abstract available

  175. LEE F, McGue S, Chapola J, Dunda W, et al
    Experiences of women participating in a human papillomavirus-based screen-triage-and treat strategy for cervical cancer prevention in Malawi.
    Front Oncol. 2024;14:1356654.
    PubMed    
    Abstract available

  176. WANG P, Gao D, Yu X, Zhu G, et al
    Value of high?risk human papillomavirus detection combined with colposcopy in the diagnosis of cervical cancer and precancerous lesions.
    Oncol Lett. 2024;27:185.
    PubMed    
    Abstract available

  177. FELIX MM, Tavares MV, Santos IP, Batista de Carvalho ALM, et al
    Cervical Squamous Cell Carcinoma Diagnosis by FTIR Microspectroscopy.
    Molecules. 2024;29:922.
    PubMed    
    Abstract available

  178. WATTANATHAVORN W, Seki M, Suzuki Y, Buranapraditkun S, et al
    Downregulation of LAMB3 Altered the Carcinogenic Properties of Human Papillomavirus 16-Positive Cervical Cancer Cells.
    Int J Mol Sci. 2024;25:2535.
    PubMed    
    Abstract available

  179. EUSTACE N, Liu J, Ladbury C, Tam A, et al
    Current Status and Future Directions of Image-Guided Adaptive Brachytherapy for Locally Advanced Cervical Cancer.
    Cancers (Basel). 2024;16:1031.
    PubMed    
    Abstract available

  180. HALD SR, Tatari CR, Kirkegaard P, Tranberg M, et al
    "Well, that Was Pretty Clever!"-Ethnic Minority Women's Views on HPV Self-Sampling Devices for Cervical Cancer Screening: Attitudes to Brushes, First-Void Urine, and Menstrual Blood Devices.
    J Racial Ethn Health Disparities. 2024 Mar 12. doi: 10.1007/s40615-024-01963.
    PubMed    
    Abstract available

  181. CAO C, Xu Q, Zhu Z, Xu M, et al
    Three-dimensional chromatin analysis reveals Sp1 as a mediator to program and reprogram HPV-host epigenetic architecture in cervical cancer.
    Cancer Lett. 2024 Mar 10:216809. doi: 10.1016/j.canlet.2024.216809.
    PubMed    
    Abstract available

  182. TALIENTO C, Scutiero G, Arcieri M, Pellecchia G, et al
    Simple hysterectomy versus radical hysterectomy in early-stage cervical cancer: A systematic review and meta-analysis.
    Eur J Surg Oncol. 2024;50:108252.
    PubMed    
    Abstract available

  183. PEREIRA MTM, Charret TS, Wermelinger GF, Nogueira TSR, et al
    Evaluation of the Antiproliferative Potential of yellow Jaboticaba (Myrciaria glazioviana) extracts against Human Cervical Cancer (HeLa cells line) and the Analysis of their Chemical Composition by HPLC-HRESIMS.
    Chem Biodivers. 2024 Mar 12:e202301467. doi: 10.1002/cbdv.202301467.
    PubMed    
    Abstract available

  184. PATEL D, Tayade S, Singh Thakur A, Singh S, et al
    Revolutionizing Early-Stage Cervical Cancer Treatment: A Comprehensive Review of Radical Trachelectomy as a Minimally Invasive Approach.
    Cureus. 2024;16:e53958.
    PubMed    
    Abstract available

  185. OLAKUNDE BO, Itanyi IU, Olawepo JO, Liu L, et al
    Comparative effectiveness of implementation strategies for Accelerating Cervical Cancer Elimination through the integration of Screen-and-treat Services (ACCESS study): protocol for a cluster randomized hybrid type III trial in Nigeria.
    Implement Sci. 2024;19:25.
    PubMed    
    Abstract available

  186. LUO Y, Liu Z, Hu X
    ceRNA Network and WGCNA Analyses of Differentially Expressed Genes in Cervical Cancer Tissues for Association with Survival of Patients.
    Reprod Sci. 2024 Mar 11. doi: 10.1007/s43032-024-01477.
    PubMed    
    Abstract available

  187. LAMICHHANE B, Adhikari B, Poudel L, Pandey AR, et al
    Factors associated with uptake of breast and cervical cancer screening among Nepalese women: Evidence from Nepal Demographic and Health Survey 2022.
    PLOS Glob Public Health. 2024;4:e0002971.
    PubMed    
    Abstract available

  188. MBWANJI G, Mazigo HD, Maganga JK, Downs JA, et al
    Female genital schistosomiasis is a neglected public health problem in Tanzania: Evidence from a scoping review.
    PLoS Negl Trop Dis. 2024;18:e0011954.
    PubMed    
    Abstract available

  189. SETAYESHI S, Hasanzadeh A, Yahyapour Y, Alizadeh A, et al
    Evaluation of human papillomavirus type 16 viral load and genome physical status in Iranian women with cervical disease.
    Mol Biol Rep. 2024;51:411.
    PubMed    
    Abstract available

  190. LIN YX, Zhao FF, Kong WM
    Effects of vaginal dilation therapy on vaginal length, vaginal stenosis, vaginal elasticity and sexual function of cervical cancer survivors.
    J Obstet Gynaecol. 2024;44:2317387.
    PubMed    
    Abstract available

  191. LU D, Chen X, Mu Y, Guo J, et al
    Clinical Efficacy of Sodium Cantharidate Vitamin B6 Combined with Concurrent Chemoradiotherapy in the Treatment of Local Advanced Cervical Cancer and its Influence on Tumor Markers.
    Altern Ther Health Med. 2024 Mar 8:AT10236.
    PubMed    
    Abstract available

  192. ALTINOK P, Ergen SA, Guzeloz Capar Z, Canyilmaz E, et al
    Awareness Level of Cervical Cancer Patients Referred to Radiation Oncology Outpatient Clinics-A Multicenter Study.
    J Low Genit Tract Dis. 2024 Mar 5. doi: 10.1097/LGT.0000000000000798.
    PubMed    
    Abstract available

  193. HAN L, Liu J, Shataer M, Wu C, et al
    The relationship between long non-coding gene CASC21 polymorphisms and cervical cancer.
    Cancer Biol Ther. 2024;25:2322207.
    PubMed    
    Abstract available

  194. MINGO BARBA S, Ademaj A, Marder D, Riesterer O, et al
    Theoretical evaluation of the impact of diverse treatment conditions by calculation of the tumor control probability (TCP) of simulated cervical cancer Hyperthermia-Radiotherapy (HT-RT) treatments in-silico.
    Int J Hyperthermia. 2024;41:2320852.
    PubMed    
    Abstract available

  195. LI C, Hua K
    Corrigendum: Dissecting the single-cell transcriptome network of immune environment underlying cervical premalignant lesion, cervical cancer and metastatic lymph nodes.
    Front Immunol. 2024;15:1386072.
    PubMed    
    Abstract available

  196. HU H, Wang Z, Xue L, Zhang T, et al
    Effects of neoadjuvant chemotherapy combined with radical laparoscopic surgery with quality nursing care on clinical efficacy and sex hormones in patients with cervical cancer.
    Am J Transl Res. 2024;16:477-486.
    PubMed    
    Abstract available

  197. SHIMELS T, Gashawbeza B, Gedif Fenta T
    Access to advanced healthcare services and its associated factors among patients with cervical cancer in Addis Ababa, Ethiopia.
    Front Oncol. 2024;14:1342236.
    PubMed    
    Abstract available

  198. IQBAL L, Jehan M, Azam S
    Advancements in mRNA Vaccines: A Promising Approach for Combating Human Papillomavirus-Related Cancers.
    Cancer Control. 2024;31:10732748241238629.
    PubMed    
    Abstract available

  199. MATSUDA Y, Nagamine Y, Irie T, Goto T, et al
    Effects of pain management using nonsteroidal anti-inflammatory drug suppositories during brachytherapy for cervical cancer: A single-center prospective observational study.
    Brachytherapy. 2024 Mar 9:S1538-4721(24)00003.
    PubMed    
    Abstract available

  200. BIZZARRI N, Fedele C, Teodorico E, Certelli C, et al
    Survival associated with the use of one-step nucleic acid amplification (OSNA) to detect sentinel lymph node metastasis in cervical cancer.
    Eur J Surg Oncol. 2024;50:108250.
    PubMed    
    Abstract available

  201. SINHA A, Ghosh A, Ghosh A, Mathai S, et al
    MAL expression downregulation through suppressive H3K27me3 marks at the promoter in HPV16-related cervical cancers is prognostically relevant and manifested by the interplay of novel MAL antisense long noncoding RNA AC103563.8, E7 oncoprotein and EZH2
    Clin Epigenetics. 2024;16:40.
    PubMed    
    Abstract available

  202. MEI J, Pan L, Huang M, Bao D, et al
    DDOST is associated with tumor immunosuppressive microenvironment in cervical cancer.
    Discov Oncol. 2024;15:69.
    PubMed    
    Abstract available

  203. GEBREEGZIABHER ZA, Semagn BE, Kifelew Y, Abebaw WA, et al
    Cervical cancer screening and its associated factors among women of reproductive age in Kenya: further analysis of Kenyan demographic and health survey 2022.
    BMC Public Health. 2024;24:741.
    PubMed    
    Abstract available

  204. FAROOQI HA, Nabi R
    Enhancing cervical cancer surveillance: Utilizing inflammatory markers for improved recurrence detection in low-resource settings and a call for prospective multi-centric studies.
    Eur J Surg Oncol. 2024 Mar 1:108239. doi: 10.1016/j.ejso.2024.108239.
    PubMed    


  205. MENG Q, Zhang Y, Sun H, Yang X, et al
    Human papillomavirus-16 E6 activates the pentose phosphate pathway to promote cervical cancer cell proliferation by inhibiting G6PD lactylation.
    Redox Biol. 2024;71:103108.
    PubMed    
    Abstract available

  206. ROBLE JG, Ligon SE, Langan KL
    Leukocytoclastic Vasculitis Localized to the Uterine Cervix.
    Hawaii J Health Soc Welf. 2024;83:81-84.
    PubMed    
    Abstract available

  207. CHOI CI, Lee SJ, Choi JB, Kim TH, et al
    2023 Korean sexually transmitted infections guidelines by the Korean Association of Urogenital Tract Infection and Inflammation: Human papillomavirus vaccination.
    Investig Clin Urol. 2024;65:108-114.
    PubMed    
    Abstract available

  208. ZHAO F, Zhou W, Xin R, Miao X, et al
    Expression and clinical diagnostic value of CCHE1 in breast cancer.
    Mutagenesis. 2024;39:141-145.
    PubMed    
    Abstract available

  209. LI Z, Qiu W, Dong J, Ying X, et al
    Colon metastasis from malignant mullerian tumor of uterine cervix: A case report.
    Asian J Surg. 2024;47:1393-1394.
    PubMed    


  210. BRENTNALL AR, Cuschieri K, Sargent A, Berkhof J, et al
    Staged design recommendations for validating relative sensitivity of self-sample human papillomavirus tests for cervical screening.
    J Clin Epidemiol. 2024;166:111227.
    PubMed    
    Abstract available

  211. ARTHUR AW, El-Zein M, Burchell AN, Tellier PP, et al
    Detection and Clearance of Type-Specific and Phylogenetically Related Genital Human Papillomavirus Infections in Young Women in New Heterosexual Relationships.
    J Infect Dis. 2024;229:691-706.
    PubMed    
    Abstract available

  212. MOHAMED AA, Shah V, Njeru JW, Wieland ML, et al
    Interventions to Increase Cancer Screening Adherence Among Somali Immigrants in the US and Europe: A Systematic Review.
    J Immigr Minor Health. 2024;26:385-394.
    PubMed    
    Abstract available

  213. ARKOUDIS NA, Kelekis NL
    Editorial for "Deep Learning Nomogram for the Identification of Deep Stromal Invasion in Patients With Early-Stage Cervical Adenocarcinoma and Adenosquamous Carcinoma: A Multicenter Study".
    J Magn Reson Imaging. 2024;59:1407-1408.
    PubMed    


  214. XIAO ML, Qian T, Fu L, Wei Y, et al
    Deep Learning Nomogram for the Identification of Deep Stromal Invasion in Patients With Early-Stage Cervical Adenocarcinoma and Adenosquamous Carcinoma: A Multicenter Study.
    J Magn Reson Imaging. 2024;59:1394-1406.
    PubMed    
    Abstract available

  215. HAKAMI MA, Hazazi A, Alsulami MO, Alsaiari AA, et al
    Mitoxantrone 2HCl's adroit activity against cervical cancer replication and maintenance proteins: a multitargeted approach.
    J Biomol Struct Dyn. 2024 Mar 22:1-14. doi: 10.1080/07391102.2024.2329796.
    PubMed    
    Abstract available

  216. VAN ANH DT, Thang VH, Dung TA, Huyen TT, et al
    Outcome and toxicity of chemoradiation using volumetric modulated arc therapy followed by 3D image-guided brachytherapy for cervical cancer: Vietnam National Cancer Hospital experience.
    Rep Pract Oncol Radiother. 2024;28:784-793.
    PubMed    
    Abstract available

  217. GUO Y, Tao M, Jiang M
    [Retracted] MicroRNA?454?3p inhibits cervical cancer cell invasion and migration by targeting c?Met.
    Exp Ther Med. 2024;27:179.
    PubMed    
    Abstract available

  218. ZHI Y, Du P, Li Y, Liu H, et al
    SOX21-AS1 Augmented Cervical Cancer Growth by Triggering FZD3 to Activate the Wnt/beta-Catenin Signaling Pathway.
    Biochem Genet. 2024 Mar 21. doi: 10.1007/s10528-024-10770.
    PubMed    
    Abstract available

  219. SRIHARIKRISHNAA S, John FE, Bairy M, Shetty S, et al
    A comprehensive review on the functional role of miRNA clusters in cervical cancer.
    Epigenomics. 2024;16:493-511.
    PubMed    
    Abstract available

  220. XU B, Qian M, Zhu L, Lu Z, et al
    Study on the Relationship Between Uncertainty Tolerance and Positive Acceptance in Postoperative Patients With Cervical Cancer.
    Cureus. 2024;16:e54414.
    PubMed    
    Abstract available

  221. WU S, Jiao J, Yue X, Wang Y, et al
    Cervical cancer incidence, mortality, and burden in China: a time-trend analysis and comparison with England and India based on the global burden of disease study 2019.
    Front Public Health. 2024;12:1358433.
    PubMed    
    Abstract available

  222. BARRISON L, Hoskins E
    Cervical cancer in a transgender man: lessons learnt to improve care.
    BMJ Case Rep. 2024;17:e258903.
    PubMed    
    Abstract available

  223. HAN M, Wang N, Han W, Liu X, et al
    Specific vaginal and gut microbiome and the anti-tumor effect of butyrate in cervical cancer women.
    Transl Oncol. 2024;44:101902.
    PubMed    
    Abstract available

  224. CIVIT-MASOT J, Luna-Perejon F, Munoz-Saavedra L, Dominguez-Morales M, et al
    A lightweight xAI approach to cervical cancer classification.
    Med Biol Eng Comput. 2024 Mar 20. doi: 10.1007/s11517-024-03063.
    PubMed    
    Abstract available

  225. ASGEDOM YS, Kebede TM, Seifu BL, Mare KU, et al
    Human papillomavirus vaccination uptake and determinant factors among adolescent schoolgirls in sub-Saharan Africa: A systematic review and meta-analysis.
    Hum Vaccin Immunother. 2024;20:2326295.
    PubMed    
    Abstract available

  226. XIE N, Mei S, Dai C, Chen W, et al
    HDAC1-Mediated Downregulation of NEU1 Exacerbates the Aggressiveness of Cervical Cancer.
    Crit Rev Eukaryot Gene Expr. 2024;34:45-54.
    PubMed    
    Abstract available

  227. SALINGAROS S, Shieh Y, Finkel ML, Polaneczky M, et al
    Public cervical cancer screening recommendations from US cancer centers: Assessing adherence to national guidelines.
    J Med Screen. 2024 Mar 20:9691413241238960. doi: 10.1177/09691413241238960.
    PubMed    
    Abstract available

  228. ZHANG XF, Wu HY, Liang XW, Chen JL, et al
    Deep-learning-based radiomics of intratumoral and peritumoral MRI images to predict the pathological features of adjuvant radiotherapy in early-stage cervical squamous cell carcinoma.
    BMC Womens Health. 2024;24:182.
    PubMed    
    Abstract available

  229. HAMBISA HD, Asfaha BT, Ambisa B, Gudeta Beyisho A, et al
    Common predictors of cervical cancer related mortality in Ethiopia. A systematic review and meta-analysis.
    BMC Public Health. 2024;24:852.
    PubMed    
    Abstract available

  230. HOLT HK, Martinez G, Reyes MF, Saraiya M, et al
    Tubal Sterilization and Cervical Cancer Underscreening in the United States.
    J Womens Health (Larchmt). 2024 Mar 19. doi: 10.1089/jwh.2023.0610.
    PubMed    
    Abstract available

  231. GARCIA-VIELMA C, Cortes-Gutierrez EI, Fernandez JL, Davila-Rodriguez MI, et al
    DBD-FISH Using Specific Chromosomal Region Probes for the Study of Cervical Carcinoma Progression.
    Methods Mol Biol. 2024;2784:271-284.
    PubMed    
    Abstract available

  232. ARBYN M, Rousta P, Bruni L, Schollin Ask L, et al
    Linkage of individual-patient data confirm protection of prophylactic human papillomavirus vaccination against invasive cervical cancer.
    J Natl Cancer Inst. 2024 Mar 19:djae042. doi: 10.1093.
    PubMed    


  233. MWENDA V, Mwangi M, Gathecha G, Kibachio J, et al
    Factors associated with late diagnosis of cervical cancer at two national referral hospitals, Kenya 2017: A case control study.
    Gynecol Oncol Rep. 2024;52:101355.
    PubMed    
    Abstract available

  234. AGIMAS MC, Adugna DG, Derseh NM, Kassaw A, et al
    Uptake of human papilloma virus vaccine and its determinants among females in East Africa: a systematic review and meta-analysis.
    BMC Public Health. 2024;24:842.
    PubMed    
    Abstract available

  235. DANTONY E, Uhry Z, Fauvernier M, Coureau G, et al
    Multidimensional penalized splines for survival models: illustration for net survival trend analyses.
    Int J Epidemiol. 2024;53:dyae033.
    PubMed    
    Abstract available

  236. TAKEKUMA M
    Challenges and perspectives on less invasive surgery for early-stage cervical cancer: a critical analysis of the SHAPE trial and its implications.
    J Gynecol Oncol. 2024;35:e48.
    PubMed    


  237. LARSON S, McAnany B, Ladd I, Gogoi R, et al
    What do cervical cancer patients know, how do they learn, and who do they tell? A pilot study.
    J Eval Clin Pract. 2024 Mar 18. doi: 10.1111/jep.13964.
    PubMed    
    Abstract available

  238. WU S, Yue X, Wang Y
    A commentary on 'Effect of preoperative radiotherapy on stage IB2 and IIA2 cervical cancer: A retrospective cohort study'.
    Int J Surg. 2024 Mar 18. doi: 10.1097/JS9.0000000000001314.
    PubMed    


  239. ALHARBI B, Alessa M, Alsayid H, Alareek L, et al
    Magnetic resonance imaging accuracy in assessing depth of invasion in tongue squamous cell carcinomas and predicting cervical nodal metastasis.
    Eur Rev Med Pharmacol Sci. 2024;28:1783-1790.
    PubMed    
    Abstract available

  240. ZHAO W, Wen S, Wang X, Wang J, et al
    Targeted regulation of miR-154-5p/Cullin2 pathway by hsa_circ_TRIM22 in promoting human papillomavirus 16 positive cervical cancer progression.
    J Cancer. 2024;15:2137-2146.
    PubMed    
    Abstract available

  241. ZHANG YM, Wang GC, Liu YJ, Wang YC, et al
    [Exploration of the method and efficacy of treatments for intractable pelvic pain caused by rectal or bladder fistula].
    Zhonghua Zhong Liu Za Zhi. 2024;46:263-268.
    PubMed    
    Abstract available

  242. LI ZM, Liang ZH, Liu N, Wei KR, et al
    [Net survival analysis of cancer in Zhongshan City of Guangdong Province in China, 1970 to 2014].
    Zhonghua Zhong Liu Za Zhi. 2024;46:232-238.
    PubMed    
    Abstract available

  243. BRUNO M, Bizzarri N, Scambia G, Ferrandina G, et al
    Reply to: 'Enhancing cervical cancer surveillance: Utilizing inflammatory markers for improved recurrence detection in low-resource settings and a call for prospective multi-centric studies'.
    Eur J Surg Oncol. 2024 Mar 12:108238. doi: 10.1016/j.ejso.2024.108238.
    PubMed    


  244. ZHANG T, Ji T, Duan Z, Xue Y, et al
    Long non-coding RNA MLLT4 antisense RNA 1 induces autophagy to inhibit tumorigenesis of cervical cancer through modulating the myosin-9/ATG14 axis.
    Sci Rep. 2024;14:6379.
    PubMed    
    Abstract available

  245. JIN T, Yin T, Xu R, Liu H, et al
    Exploring the role of disulfidptosis-related signatures in immune microenvironment, prognosis and therapeutic strategies of cervical cancer.
    Transl Oncol. 2024;44:101938.
    PubMed    
    Abstract available

  246. KOMATSU H, Matsumoto K, Morita M, Nagasawa T, et al
    A survey of carboplatin desensitization therapy in Japan: A multicenter retrospective study.
    Cancer Med. 2024;13:e6968.
    PubMed    
    Abstract available

  247. ALATTAS M, Gordon S, Sabin LL, El-Jardali F, et al
    Equity and unmet need of non-communicable diseases services in Saudi Arabia using a National Household Survey (2019).
    BMC Health Serv Res. 2024;24:346.
    PubMed    
    Abstract available

  248. SRISUTTAYASATHIEN M, Kantathavorn N, Luasiripanthu T, Petchjorm S, et al
    Correlation between P16/Ki67 in cervical cytology and diagnosis of cervical intraepithelial neoplasia 2-3 in Thai women infected with high-risk types of human papillomavirus.
    Taiwan J Obstet Gynecol. 2024;63:192-198.
    PubMed    
    Abstract available

  249. HANDE V, Ranjan N, Chopra S, Sinha S, et al
    Longitudinal Costs of Image-Guided Intensity-Modulated Radiation Therapy Versus Three-Dimensional Conformal Radiation: Lessons From Phase III PARCER Trial for Shaping Resource-Stratified Guidelines in Low- and Middle-Income Countries.
    JCO Glob Oncol. 2024;10:e2300478.
    PubMed    
    Abstract available

  250. COURT LE, Aggarwal A, Jhingran A, Naidoo K, et al
    Artificial Intelligence-Based Radiotherapy Contouring and Planning to Improve Global Access to Cancer Care.
    JCO Glob Oncol. 2024;10:e2300376.
    PubMed    
    Abstract available

  251. YANG X, Ding B, Qin J, Guo L, et al
    HVS-Unsup: Unsupervised cervical cell instance segmentation method based on human visual simulation.
    Comput Biol Med. 2024;171:108147.
    PubMed    
    Abstract available

  252. FANG M, Fu M, Liao B, Lei X, et al
    Deep integrated fusion of local and global features for cervical cell classification.
    Comput Biol Med. 2024;171:108153.
    PubMed    
    Abstract available

  253. GHOUNEIMY A, Ali Z, Aman R, Jiang W, et al
    CRISPR-Based Multiplex Detection of Human Papillomaviruses for One-Pot Point-of-Care Diagnostics.
    ACS Synth Biol. 2024;13:837-850.
    PubMed    
    Abstract available

  254. SHIM SH, Lee JY, Lee YY, Park JY, et al
    Major clinical research advances in gynecologic cancer in 2023: a tumultuous year for endometrial cancer.
    J Gynecol Oncol. 2024;35:e66.
    PubMed    
    Abstract available

  255. YANG D, Lu X, Zhang X, Zhang X, et al
    RACK1 promotes the occurrence and progression of cervical carcinoma.
    J Clin Lab Anal. 2024;38:e25012.
    PubMed    
    Abstract available

  256. ZHAO D, Sun S, Yang Z, Wang P, et al
    The impact of neo/adjuvant treatment choices on prognosis for surgically treated small-cell neuroendocrine carcinoma of the cervix.
    Neoplasma. 2024;71:70-76.
    PubMed    
    Abstract available

  257. JONES KF, Osazuwa-Peters OL, Des Marais A, Merlin JS, et al
    Substance Use Disorders Among US Adult Cancer Survivors.
    JAMA Oncol. 2024;10:384-389.
    PubMed    
    Abstract available

  258. CHOI HC, Leung K, Wu JT
    Cervical screening among Chinese females in the era of HPV vaccination: a population-based survey on screening uptake and regular screening following an 18-year organized screening program.
    J Gynecol Oncol. 2024;35:e20.
    PubMed    
    Abstract available

  259. KEFALE B, Engidaw MT, Tesfa D, Molla M, et al
    Medication-related problems among patients with cervical cancers at oncology centers of University of Gondar comprehensive specialized hospital: A hospital-based retrospective study.
    J Oncol Pharm Pract. 2024;30:270-277.
    PubMed    
    Abstract available

  260. WANG Y, He M, He T, Ouyang X, et al
    Integrated genomic and transcriptomic analysis reveals the activation of PI3K signaling pathway in HPV-independent cervical cancers.
    Br J Cancer. 2024 Jan 22. doi: 10.1038/s41416-023-02555.
    PubMed    
    Abstract available

  261. MICHEL AD, Fontenot HB, Fuzzell L, Brownstein NC, et al
    Attitudes toward the American Cancer Society's 2020 cervical cancer screening guidelines: A qualitative study of a national sample of US clinicians.
    Cancer. 2024 Mar 4. doi: 10.1002/cncr.35269.
    PubMed    
    Abstract available

  262. NIERENGARTEN MB
    Promising new treatment approaches for locally advanced cervical cancer.
    Cancer. 2024;130:1192.
    PubMed    


  263. LEE KH, Kim NI, Nam JH, Kim SS, et al
    Gastric-type adenocarcinoma of the uterine cervix presenting in urine cytology specimens: A case report and literature review.
    Diagn Cytopathol. 2023 Dec 22. doi: 10.1002/dc.25268.
    PubMed    
    Abstract available

  264. MAHAJAN P, Kaur P
    Improving cervical cancer classification in PAP smear images with enhanced segmentation and deep progressive learning-based techniques.
    Diagn Cytopathol. 2024 Mar 22. doi: 10.1002/dc.25295.
    PubMed    
    Abstract available

  265. COLONETTI T, Rodrigues Uggioni ML, Meller Dos Santos AL, Michels Uggioni N, et al
    Self-sampling for HPV testing in cervical cancer screening: A scoping review.
    Eur J Obstet Gynecol Reprod Biol. 2024;296:20-51.
    PubMed    
    Abstract available

  266. ALVES FIRMEZA M, de Vasconcelos Oliveira NM, Mendes Alves F, Teixeira Moreira Vasconcelos C, et al
    Urinary symptoms and sexual function after hysterectomy secondary to cervical cancer: A prospective, cohort study.
    Eur J Obstet Gynecol Reprod Biol. 2024;296:208-214.
    PubMed    
    Abstract available

  267. ASHMORE AA, Abdul S, Phillips A, Bali A, et al
    Regular follow-up with cervical cytology is of questionable value following surgical treatment of microinvasive cervical cancer.
    Eur J Obstet Gynecol Reprod Biol. 2024;296:307-310.
    PubMed    
    Abstract available

  268. PELTECU G
    Eugen Bogdan Aburel, a pioneer of fertility sparing surgery.
    Gynecol Oncol. 2024;181:40-45.
    PubMed    
    Abstract available

  269. ROSS DH, Gomez K, Harmon G, Mysz ML, et al
    Evaluating outcomes and toxicities for a newly implemented MRI-based brachytherapy program for cervical cancer.
    Gynecol Oncol. 2024;183:33-38.
    PubMed    
    Abstract available

  270. GASS P, Thiel FC, Haberle L, Ackermann S, et al
    Primary results of the AGO-Zervix-1 Study: A prospective, randomized phase III study to compare the effects of paclitaxel and topotecan with those of cisplatin and topotecan in the treatment of patients with recurrent and persistent cervical cancer.
    Gynecol Oncol. 2024;183:25-32.
    PubMed    
    Abstract available

  271. LI N, Yi H, Sun W, Sundquist J, et al
    Revealing genes associated with cervical cancer in distinct immune cells: A comprehensive Mendelian randomization analysis.
    Int J Cancer. 2024 Mar 6. doi: 10.1002/ijc.34911.
    PubMed    
    Abstract available

  272. STERPETTI AV, Gabriele R, Iannone I, Sapienza P, et al
    Reduced adherence to cervical cancer screening. The importance of information and education for women with low education and low-income.
    Int J Cancer. 2024 Mar 6. doi: 10.1002/ijc.34907.
    PubMed    


  273. OLTHOF EMG, Aitken CA, Siebers AG, van Kemenade FJ, et al
    The impact of loss to follow-up in the Dutch organised HPV-based cervical cancer screening programme.
    Int J Cancer. 2024 Mar 4. doi: 10.1002/ijc.34902.
    PubMed    
    Abstract available

  274. PATEL A, Suneja A, Malik R, Gupta B, et al
    Chromocolposcopy with fluorescein sodium for detection of premalignant and malignant lesions of the cervix: A cross-sectional study.
    Int J Gynaecol Obstet. 2024;165:169-175.
    PubMed    
    Abstract available

  275. FOTOPOULOU C, Eriksson AG, Planchamp F, Morice P, et al
    European Society of Gynaecological Oncology expanded quality indicators and accreditation for cervical cancer management.
    Int J Gynecol Cancer. 2024 Feb 23:ijgc-2024-005293.
    PubMed    


  276. JAYRAJ AS, Singhal S
    The beginning of the end for cervical cancer in India.
    Int J Gynecol Cancer. 2024 Mar 7:ijgc-2024-005420. doi: 10.1136/ijgc-2024-005420
    PubMed    


  277. VIVEROS-CARRENO D, Pareja R, Plante M
    De-escalation of surgical radicality for non-fertility preserving management in patients with early-stage cervical cancer: a systematic review.
    Int J Gynecol Cancer. 2024;34:386-392.
    PubMed    
    Abstract available

  278. PETERS I, Marchetti C, Scambia G, Fagotti A, et al
    New windows of surgical opportunity for gynecological cancers in the era of targeted therapies.
    Int J Gynecol Cancer. 2024;34:352-362.
    PubMed    
    Abstract available

  279. WESS B, Kohler C, Plaikner A, El-Safadi S, et al
    Comparative study using indocyanine green and patent blue dye for sentinel lymph node biopsy in patients with early-stage cervical cancer.
    Int J Gynecol Cancer. 2024 Mar 14:ijgc-2023-005206.
    PubMed    
    Abstract available

  280. DEL M, Illac C, Morisseau M, Angeles MA, et al
    Intraepithelial tumor-infiltrating lymphocytes shape loco-regional PET/CT spread of locally advanced cervical cancer.
    Int J Gynecol Cancer. 2024 Mar 12:ijgc-2023-004677.
    PubMed    
    Abstract available

  281. CHOW Z, Fabian D
    Cervical Cancer With Vaginal Recurrence and Prior Pelvic Radiation.
    Int J Radiat Oncol Biol Phys. 2024;118:886-887.
    PubMed    


  282. GEORGE J, Tuli S, Patel PP, Monare B, et al
    Delays in cervical cancer treatment initiation for patients living with or without HIV in Botswana: An observational cohort analysis (2015-2019).
    Int J Radiat Oncol Biol Phys. 2024 Mar 8:S0360-3016(24)00354.
    PubMed    
    Abstract available

  283. YILMAZ E, Eklund C, Lagheden C, Robertsson KD, et al
    Corrigendum to "First international proficiency study on human papillomavirus testing in cervical cancer screening" [J Clin Virol. 2023 Oct;167:105581].
    J Clin Virol. 2024;171:105660.
    PubMed    


  284. PRETET JL, Arroyo Muhr LS, Cuschieri K, Fellner MD, et al
    Human papillomavirus negative high grade cervical lesions and cancers: Suggested guidance for HPV testing quality assurance.
    J Clin Virol. 2024;171:105657.
    PubMed    
    Abstract available

  285. HEIDEMAN DAM, Berkhof J, Verhoef L, Ouwerkerk C, et al
    Validation of the clinical performance and reproducibility of the NeuMoDx HPV assay self-sample workflow.
    J Clin Virol. 2024;171:105649.
    PubMed    
    Abstract available

  286. HUI C, Ewongwo A, Mendoza MG, Kozak MM, et al
    Less than whole uterus irradiation for patients with locally advanced cervical cancer.
    Radiother Oncol. 2024 Mar 2:110199. doi: 10.1016/j.radonc.2024.110199.
    PubMed    
    Abstract available

  287. KUIPERS SC, Godart J, Corbeau A, Breedveld S, et al
    Dosimetric impact of bone marrow sparing for robustly optimized IMPT for locally advanced cervical cancer.
    Radiother Oncol. 2024 Mar 10:110222. doi: 10.1016/j.radonc.2024.110222.
    PubMed    
    Abstract available

  288. BONLOKKE S, Blaakaer J, Steiniche T, Iachina M, et al
    Social factors and age play a significant role in cervical cancer and advanced-stage disease among Danish women.
    BMC Cancer. 2024;24:259.
    PubMed    
    Abstract available

  289. KHANNA D, Sharma P, Budukh A, Vishwakarma R, et al
    Rural-urban disparity in cancer burden and care: findings from an Indian cancer registry.
    BMC Cancer. 2024;24:308.
    PubMed    
    Abstract available

  290. ZHANG Y, Liu S, Chen M, Ou Q, et al
    Preimmunization with Listeria-vectored cervical cancer vaccine candidate strains can establish specific T-cell immune memory and prevent tumorigenesis.
    BMC Cancer. 2024;24:288.
    PubMed    
    Abstract available

  291. CUI X, Wang H, Chen M, Seery S, et al
    Assessing colposcopy competencies in medically underserved communities: a multi-center study in China.
    BMC Cancer. 2024;24:349.
    PubMed    
    Abstract available

  292. GHASEMI M, Savabi-Esfahani M, Noroozi M, Satari M, et al
    Prediction of cervical cancer screening: application of the information-motivation-behavioral skills model.
    BMC Cancer. 2024;24:351.
    PubMed    
    Abstract available

  293. YAO B, Peng J, Song W, Yang L, et al
    Real-world effectiveness of cytology and HPV-based screening strategy in cervical cancer screening: A cross-sectional population-based study in Chengdu, China.
    PLoS One. 2024;19:e0299651.
    PubMed    
    Abstract available

  294. SUN J, Frick KD, Liang H, Chow CM, et al
    Examining cancer screening disparities by race/ethnicity and insurance groups: A comparison of 2008 and 2018 National Health Interview Survey (NHIS) data in the United States.
    PLoS One. 2024;19:e0290105.
    PubMed    
    Abstract available

  295. ZHANG J, Yuan J, Zhang D, Yang Y, et al
    Short video platforms as sources of health information about cervical cancer: A content and quality analysis.
    PLoS One. 2024;19:e0300180.
    PubMed    
    Abstract available

  296. CAROZZI FM, Royder Yanez R, Paganini I, Sani C, et al
    Cervical cancer prevention: Feasibility of self-sampling and HPV testing in rural and urban areas of Bolivia: An observational study.
    PLoS One. 2024;19:e0292605.
    PubMed    
    Abstract available

  297. LIU Z, Fan T, Mo X, Kan J, et al
    Association between multiple sclerosis and cancer risk: A two-sample Mendelian randomization study.
    PLoS One. 2024;19:e0298271.
    PubMed    
    Abstract available

  298. LIN Y, Long Y, He J, Yi Q, et al
    The residual rate of HPV and the recurrence rate of CIN after LEEP with negative margins: A meta-analysis.
    PLoS One. 2024;19:e0298520.
    PubMed    
    Abstract available

  299. LOWY DR
    Harald zur Hausen (1936 to 2023): Discoverer of human papillomavirus infection as the main cause of cervical cancer.
    Proc Natl Acad Sci U S A. 2024;121:e2400517121.
    PubMed    



Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.


;